What to Know About Bioidentical Hormones in a Clinical Approach

Discover the benefits of bioidentical hormones in a clinical approach hormones and its impact on your overall health journey.

Navigating Hormone Insufficiency: An Evidence-Based Approach to Balancing Your Body and Mind

As both a Doctor of Chiropractic (DC) and a Family Nurse Practitioner (FNP-APRN), I build my clinical practice on a foundation of integrative and holistic care. I see a wide spectrum of patients, and a recurring theme that surfaces daily is the profound and often misunderstood impact of hormone insufficiency on their quality of life. Many individuals come to my clinic, HealthVoice360.com, describing a constellation of symptoms that have left them feeling disconnected from themselves. They use phrases like, “I feel like I’m going crazy,” or “I’ve lost the drive to do the things I once enjoyed.” This isn’t just a matter of feeling a little “off”; it’s a deep-seated disruption that affects their mental, emotional, and physical well-being. Men and women alike present with issues ranging from debilitating anxiety and brain fog to chronic pain and an inability to lose weight. For women, it can manifest as hot flashes, night sweats, and a complete loss of libido. For men, it often presents as a frustrating lack of stamina, decreased muscle mass, and erectile dysfunction. In my years of practice, I’ve observed a conventional approach that often focuses on treating these symptoms in isolation. Depression is met with an SSRI, anxiety with an anxiolytic, and chronic pain with analgesics. While these medications certainly have their place and can be life-saving for many, especially in cases of severe major depressive disorder, this symptom-based approach can sometimes miss the underlying root cause: a fundamental imbalance in the body’s endocrine system. The latest evidence-based research, conducted by leading figures in hormone therapy, compels us to look more deeply. Modern research methods are illuminating the intricate connections between our hormones—specifically testosterone and estrogen—and our overall health. The findings strongly suggest that by addressing the foundational hormonal deficiencies, we can often alleviate the very symptoms we were trying to manage individually, leading to a more comprehensive and sustainable state of wellness. This educational post aims to delve into this complex world of hormone replacement therapy (HRT), moving beyond outdated notions and focusing on the most current, evidence-based modalities. We will explore the multifaceted symptoms of hormone insufficiency, dissecting how low testosterone and estrogen levels can manifest differently in men and women. I will share insights from my own clinical observations at HealthVoice360.com, bridging the gap between scientific research and real-world patient experiences. We will critically evaluate the various methods of hormone delivery, from traditional creams and injections to the more advanced and nuanced option of subcutaneous bioidentical hormone pellets. I will detail the physiological rationale behind each method, explaining why some are more effective for systemic relief than others. A significant portion of our discussion will focus on the science of pellet therapy, a modality I have extensive experience with. We will examine how innovations, such as the inclusion of triamcinolone to reduce inflammation and ethylcellulose to achieve sustained release, have revolutionized patient outcomes by minimizing side effects and maintaining stable hormone levels. By understanding the “why” behind these protocols—the pharmacokinetics, the physiological mechanisms, and the individualized dosing strategies—you will gain a clearer picture of what modern, sophisticated hormone optimization looks like. This is not about a one-size-fits-all solution but about a tailored, scientific approach to restoring balance and reclaiming vitality.

As a clinician with dual qualifications in chiropractic care (DC) and as an Advanced Practice Registered Nurse and Family Nurse Practitioner (FNP-APRN), I have dedicated my career to integrating holistic principles with advanced, evidence-based medical practices. My focus is on functional and regenerative medicine, particularly hormone optimization. In my years of clinical practice, I have witnessed firsthand the profound impact hormonal imbalances can have on an individual’s quality of life—spanning energy levels, mental clarity, mood, body composition, and overall well-being. This educational post distills years of clinical experience and the latest scientific research into a comprehensive guide to understanding and implementing effective hormone replacement therapy (HRT). We will move beyond outdated paradigms and embrace a modern, data-driven approach that prioritizes patient symptoms and physiological outcomes over rigid adherence to often misleading laboratory reference ranges. This deep dive into hormone optimization is structured to provide a clear, narrative exploration of the essential concepts, from foundational lab work and diagnostic interpretation to nuanced treatment strategies and patient management protocols. We will begin by establishing the crucial baseline laboratory panels for both female and male patients. Understanding the “why” behind each test—from Follicle-Stimulating Hormone (FSH) and estradiol to testosterone, thyroid panels, and inflammatory markers like C-Reactive Protein (CRP)—is the first step toward creating a personalized and effective treatment plan. We will then transition to a detailed discussion of interpreting these results, with a special focus on the clinical utility of FSH as the most reliable indicator of menopausal status and a guide to estrogen dosing. I will share insights into the delicate feedback loop between estrogen and FSH and explain why chasing fluctuating daily estrogen levels is a common pitfall in perimenopausal management. A significant portion of this post is dedicated to unraveling the complexities surrounding testosterone therapy, particularly for female patients. Drawing upon groundbreaking studies from leading researchers like Dr. Rebecca Glaser, a breast cancer surgeon who champions the use of testosterone, we will dismantle the long-held, but poorly supported, notion that serum testosterone levels must be kept within narrow, often arbitrary limits. I will present a compelling case, supported by robust scientific literature, for why symptom resolution and physiological outcomes are far more critical than a single number on a lab report. We will explore the concept of androgen insufficiency syndrome, the limitations of current testing methodologies in capturing the full picture of cellular-level hormone activity, and why pharmacological dosing is often necessary to achieve a therapeutic effect.

Furthermore, I will introduce powerful adjunctive therapies, such as nutraceuticals containing Shilajit, that can enhance free testosterone and improve patient outcomes without necessitating excessively high total testosterone levels. Beyond individual hormones, this post outlines a holistic, integrated treatment methodology I call the “Optimization Pyramid.” This framework emphasizes a structured, layered approach to patient care. It begins with a thorough initial screening and documentation, followed by the optimization of sex hormones using bioidentical hormone replacement therapy (BHRT), often in the form of pellets. From this foundation, we strategically address other critical areas, including thyroid function, gut health, and adrenal support with DHEA. I will provide practical clinical pearls for managing various patient scenarios, such as transitioning patients from other forms of HRT, safely addressing perimenopausal symptoms with low-dose estrogen, and navigating HRT in special populations, including breastfeeding mothers. We will also cover protocols for safely weaning patients off SSRIs when their depressive symptoms are rooted in hormonal deficiencies. Finally, we will walk through the follow-up process, explaining the importance of the three- to five-month cadence, the role of “boosting” doses, and how to use data from our comprehensive dosing calculator to refine treatment plans over time. This post is my effort to share the art and science of hormone optimization, empowering patients and practitioners with the knowledge to restore vitality and transform health.

The Pervasive Symptoms of Hormone Insufficiency: A Clinical Perspective

In my practice, the conversation often begins with a patient expressing a profound sense of distress, a feeling of being fundamentally unwell that they can’t quite pinpoint. They’ll say, “I feel crazy,” or describe an uncharacteristic rage or irritability, confessing, “I feel like I’m going to kill people,” and immediately feel terrible for even having the thought. This isn’t hyperbole; it’s a raw and honest description of the psychological turmoil that can accompany severe hormonal imbalance. I see this presentation consistently in patients with clinically low testosterone, and it affects both women and men, whether they are young, middle-aged, or post-menopausal.

The symptom profile is remarkably consistent. Patients describe feeling irritable, anxious, and cerebrally “foggy.” They struggle with concentration, memory, and mental clarity. Sleep disturbances are almost universal; they either can’t fall asleep, can’t stay asleep, or wake up feeling completely unrefreshed. A core feature is a profound lack of drive and motivation. They’ll tell me, “I just can’t find my get-up-and-go.” The activities they once cherished, the hobbies that brought them joy, now feel like insurmountable chores. This loss of interest, or anhedonia, is a classic symptom of depression. Still, in this context, it is directly linked to the absence of the neuro-stimulatory and mood-regulating effects of adequate testosterone.

Distinct Manifestations in Men and Women

While many symptoms overlap, there are distinct differences in how this deficiency presents in men and women.

Men’s Health and Low Testosterone

For men, a significant and distressing complaint is a lack of stamina. This isn’t just about athletic performance; it’s a pervasive fatigue that impacts their entire day. They feel physically and mentally drained long before the day is over. Libido is also a major issue. Many men will still report having a desire for intimacy—they “want it”—but they struggle with performance. The physiological ability to achieve and maintain an erection becomes a source of immense frustration and can strain relationships. This is a crucial distinction: the drive may persist even as physical capacity diminishes, a hallmark of declining testosterone levels that affect vascular and neurological function. This performance issue, coupled with general recklessness or increased risk-taking, is a more common symptom pattern in males.

Women’s Health and Hormone Deficiencies

For women, the libido issue often presents differently. Many women report a complete and total loss of sexual desire. It’s not just a physical issue; the mental and emotional drive is gone. I had a patient once tell me, “My husband could be the most attractive man on the planet, and I would rather read a book.” This sentiment, a complete shutdown of libido, is something I hear echoed by countless female patients. It’s not a reflection of their relationship; it’s a physiological state driven by hormonal decline.

Beyond libido, women experience a unique set of physical symptoms. Hot flashes during the day and drenching night sweats are classic signs, often mistakenly attributed solely to estrogen deficiency. However, my clinical experience, supported by emerging research, shows a strong correlation between these vasomotor symptoms and low testosterone as well. Stubborn weight gain, particularly around the midsection, or an inability to lose weight despite diligent diet and exercise, is another common and frustrating complaint. Furthermore, many women with low hormone levels are diagnosed with chronic pain syndromes like fibromyalgia. The connection is so strong that when I see a patient with a fibromyalgia diagnosis, one of the first things I investigate is their hormone status. Testosterone and estrogen have powerful anti-inflammatory properties, and their absence can amplify pain perception and contribute to systemic inflammation.

The Conventional Treatment Pitfall

When a patient presents with this cluster of symptoms—depression, anxiety, fatigue, pain—the standard medical response is often to treat each symptom individually. They are frequently prescribed an SSRI (Selective Serotonin Reuptake Inhibitor) for depression, an anxiolytic for anxiety, or a sleep aid for insomnia. While these medications are indispensable tools, especially in managing conditions like biochemically driven major depressive disorder, where studies show over 80% of patients may require an SSRI as part of their initial treatment, this approach can be incomplete. It can function as a bandage, covering the symptoms without addressing the foundational hormonal imbalance that may be driving them.

My goal, and the focus of modern, evidence-based hormone therapy, is to shift this paradigm. It’s not about abandoning these necessary medications, but about investigating the underlying physiology. The crucial question becomes: how can we replace the deficient hormones to restore the body’s natural equilibrium? By doing so, we can often reduce or even eliminate the need for some of these symptomatic treatments. Our patients’ own experiences guide us; when their hormones are optimized, they consistently report that the fog lifts, the pain lessens, and the joy in life returns. This is the ultimate goal: to treat the root cause, not just the downstream effects.

Foundational Laboratory Analysis: Establishing a Comprehensive Baseline

In my practice, we operate on a principle of thoroughness and precision. Before any therapeutic intervention is considered, we must establish a comprehensive, detailed understanding of the patient’s unique physiological landscape. This is not just about identifying deficiencies; it’s about mapping the intricate interplay of various biological systems. While we have a detailed practice manual outlining our protocols and providing all necessary forms to our patients, it’s essential to understand the core laboratory panels that form the non-negotiable foundation of our diagnostic process.

For our female patients, the minimum required labs to initiate an evaluation for hormone replacement therapy include:

• Follicle-Stimulating Hormone (FSH): This is a critical marker, especially for determining menopausal status.
• Estradiol (Estrogen): To assess the primary female sex hormone.
• Thyroid Panel: At a minimum, it should include Thyroid-Stimulating Hormone (TSH); a comprehensive panel is preferred.
• Complete Blood Count (CBC): This provides a snapshot of overall health, including red and white blood cells, hemoglobin, and hematocrit.
• Comprehensive Metabolic Panel (CMP): This assesses kidney and liver function, electrolyte balance, and blood glucose.

This baseline is the absolute minimum. However, to practice a truly comprehensive and functional form of medicine, we must look deeper. In our clinic, we expand this initial panel significantly to capture a more holistic view of the patient’s health. Our standard comprehensive panel for women includes:

• Vitamin D (25-Hydroxy): Essential for bone health, immune function, and mood regulation.
• Vitamin B12: Crucial for nerve function, energy production, and red blood cell formation.
• Hemoglobin A1c (HbA1c): A marker for long-term blood sugar control.
• C-Reactive Protein (CRP), High-Sensitivity: An important indicator of systemic inflammation.
• DHEA-Sulfate (DHEA-S): A precursor hormone produced by the adrenal glands, often referred to as an “anti-aging” hormone.
• Ferritin: To assess iron stores, which are vital for energy and preventing anemia.

For our male patients, the foundational and comprehensive panels are equally robust. Many are often surprised by the breadth of labs we run. We meticulously examine hormone levels, metabolic markers, and indicators of systemic health. The essential labs for men include:

• Total and Free Testosterone: To evaluate androgen status.
• Thyroid Panel (TSH, Free T3, Free T4): Thyroid function is intimately linked with testosterone and overall metabolism.
• Complete Blood Count (CBC): As with women, it is used to assess overall health.
• Comprehensive Metabolic Panel (CMP): To monitor organ function and metabolic health.
• Prostate-Specific Antigen (PSA): As a screening tool for prostate health, especially for men in the appropriate age groups.

In our office, as a matter of standard procedure and for the safety and comprehensive care of our patients, we obtain a baseline PSA on all our adult male patients, regardless of age. However, we acknowledge and respect that practitioners can also follow the specific age-related guidelines from the American Urological Association (AUA). Additionally, our comprehensive male panel often includes a full iron panel, as iron status can significantly affect energy and overall vitality.

With this wealth of baseline data, we are equipped to move beyond simple diagnoses and begin crafting a truly personalized therapeutic strategy. These labs are not just numbers on a page; they are the starting point of a conversation between the patient’s body and our clinical expertise. They allow us to ask the right questions and determine the most effective course of action. So, let’s delve into how we interpret these results and use them to guide our treatment decisions.

Interpreting FSH and Estrogen: The Key to Menopausal Status

Once we have our baseline lab results, the real work of clinical interpretation begins. One of the most critical aspects of this process, particularly for our female patients, is understanding the dynamic relationship between Follicle-Stimulating Hormone (FSH) and estrogen. When evaluating a woman for post-menopausal status, FSH is unequivocally the most accurate and reliable biochemical marker. While other modalities and opinions exist, the evidence consistently supports the primacy of FSH in this diagnostic context.

The regulation of FSH and estrogen operates through a classic negative feedback loop, much like the relationship between Thyroid-Stimulating Hormone (TSH) and thyroid hormones. The pituitary gland in the brain secretes FSH, which travels to the ovaries and stimulates them to produce estrogen. When the ovaries are healthy and producing ample estrogen, that estrogen signals the pituitary to slow its production of FSH. Conversely, as a woman enters perimenopause and menopause, her ovarian function declines, and estrogen production wanes. The pituitary senses this drop in estrogen and, in an attempt to stimulate the failing ovaries, ramps up its secretion of FSH.

Therefore, the relationship is inverse:

• Low estrogen leads to High FSH.
• High estrogen leads to suppressed FSH.

We can observe this feedback loop clearly in various clinical scenarios. For instance, women taking oral contraceptive pills, which contain synthetic estrogen and progestin, typically have very suppressed FSH. The exogenous hormones from the pill signal to the pituitary that there is plenty of estrogen in circulation, so the pituitary’s own production of FSH is shut down. On the other end of the spectrum, postpartum women often experience a temporary state of low estrogen, which can result in a transiently elevated FSH.

A common question I receive from other practitioners is about how to manage a patient based on a single estrogen reading. For example, “I have a patient whose lab work came back with an estrogen level of 20 pg/mL. Should I start her on estrogen therapy?” My first and most important follow-up question is always: “Is she still having a menstrual cycle?” If the answer is yes, it means her body is still producing its own estrogen in a cyclical pattern. An estrogen level of 20 might reflect the follicular phase of her cycle, and a week later, it could surge to 200 or 300 at ovulation. Giving exogenous estrogen to a woman who is still menstruating cyclically is inappropriate and can lead to significant problems. We do not want to “chase” these fluctuating estrogen levels in a premenopausal or perimenopausal woman. A single, low estrogen value in a cycling woman is not an indication for estrogen replacement.

This brings us to a crucial point about scientific evidence. While I won’t delve deeply into every specific study here, it is important to know that the research supports our methods. For instance, a notable two-year study on women using hormone pellets demonstrated the ability to maintain consistent physiological hormone levels. My goal, and the goal of evidence-based HRT, is not to create “super-physiological” levels that are unnaturally high. Instead, it is to restore hormones to a healthy, youthful, and functional state, guided by both lab values and, most importantly, the patient’s clinical response. The research provides a strong foundation for the safety and efficacy of this approach when done correctly.

Utilizing FSH to Guide Treatment Decisions

The Follicle-Stimulating Hormone (FSH) is more than just a diagnostic marker for menopausal status; it is a powerful tool for guiding our therapeutic decisions, especially in complex clinical situations. Consider the common scenario of a 50-year-old woman who has been on oral contraceptive pills for years. She wants to know if she is post-menopausal and if she can safely discontinue the pill. We certainly don’t want a 50-year-old to have an unintended pregnancy, but we also recognize the increased thrombotic risks (blood clots) associated with continuing combination oral contraceptives in this age group.

Here’s how we use FSH to navigate this decision:

If she is currently on the pill and we test her FSH, and the level is greater than 30 mIU/mL, this is a strong indicator that she is post-menopausal. The high FSH shows that her pituitary is screaming for her ovaries to respond, but they are not, signifying ovarian senescence. In this case, she can likely stop the pill and transition to a more appropriate form of hormone replacement therapy.

If her FSH is in a gray area, for example, less than 30 but still elevated (perhaps in the 10-25 range), she might be in the late stages of perimenopause. In this situation, I would strongly consider transitioning her to another form of contraception that does not carry the same systemic risks as oral estrogen, such as a progestin-only IUD or other non-hormonal methods. This is a much safer option for a woman in her late 40s or early 50s. If she is on the pill and her FSH is in the low single digits, she is likely still premenopausal, and we would wait and re-evaluate later.

When we see patients who are definitely post-menopausal, they often present with a very high baseline FSH, sometimes 100 mIU/mL or more. It is my clinical observation that the higher the initial FSH, the more severe their menopausal symptoms—the hot flashes, night sweats, brain fog, and mood swings—tend to be. The goal of our HRT, particularly when using subcutaneous hormone pellets, is to administer enough estrogen to provide symptom relief and, in doing so, to suppress the elevated FSH.

This suppression is a measurable indicator of therapeutic success. Let’s walk through a typical case. A woman comes to my clinic with a baseline FSH of 100. She is experiencing debilitating menopausal symptoms. We initiate treatment with an appropriate dose of estradiol pellets. When she returns for her follow-up labs in 4-6 weeks, her FSH has dropped to 40. This is a fantastic result. My initial goal with the first pellet insertion is to cut the FSH by at least half. An FSH reduction from 100 to 40 indicates that the dose is effective, estrogen is being absorbed, and the pituitary is receiving the feedback it needs.

Now, our long-term, incremental goal is to bring her FSH down even further, ideally into the low 20s. Extensive research and clinical experience have shown that an FSH level below 25 is correlated with significantly better outcomes. This includes not just symptom relief but also improvements in all-cause mortality, cardiovascular health, bone density, and body composition. After her second, third, or fourth pellet insertion, as we fine-tune her dosing, I expect to see that FSH settle into that optimal range of around 20. At this level, patients not only feel their absolute best, but we are also providing them with the maximum long-term protective benefits of hormone optimization. The FSH level serves as our biological compass, guiding us toward the perfect dose for each patient.

Modulating Women’s Hormones-Video

A Critical Evaluation of Hormone Replacement Methods

When we discuss restoring hormone balance, the conversation naturally turns to the “how.” How do we safely and effectively deliver estrogen and testosterone back into the body? The method of delivery is not a trivial detail; it profoundly affects efficacy, patient experience, and the side-effect profile. Over the years, I have worked with numerous modalities, and science has guided us toward more sophisticated and physiologically sound options. Let’s break down the most common methods and evaluate their pros and cons based on current research and extensive clinical observation.

Creams and Transdermal Applications: Limited and Localized

Transdermal creams are a very common starting point for hormone replacement. They are non-invasive and seem simple to use. We have creams for testosterone, estradiol, and DHEA. However, for achieving systemic effects—that is, raising hormone levels throughout the body to alleviate symptoms such as fatigue, brain fog, and chronic pain—their performance is inconsistent and often disappointing.

The primary issue with most transdermal creams is poor absorption. When applied to typical areas such as the arms or abdomen, the skin barrier prevents a significant amount of the hormone from entering the bloodstream. This leads to unpredictable, often subtherapeutic systemic levels. You cannot achieve the stable, effective hormone concentrations needed for comprehensive symptom relief.

However, creams do have a valuable, albeit niche, role. Their strength lies in localized treatment.

• Vaginal Health: For women suffering from vaginal atrophy, dryness, and pain with intercourse (dyspareunia), a direct application of an estradiol cream can be incredibly effective. A compounded cream or a commercially prescribed product like Estrace® can restore the health, elasticity, and lubrication of the vaginal tissues without needing to create high systemic estrogen levels.
• Libido and Clitoral Sensitivity: When using testosterone or DHEA for localized effects, the site of application is critical. The skin of the scrotum in men and the labia in women is highly vascular and much thinner than skin elsewhere on the body. This allows for significantly better absorption. Labial application of a testosterone or DHEA cream can be excellent for women experiencing low libido or diminished orgasmic intensity. The reason this works so well is tied to a specific metabolic pathway. Testosterone is a prohormone, and in the presence of the enzyme 5-alpha reductase, it is converted to dihydrotestosterone (DHT). The clitoris and labia are rich in DHT receptors. This localized conversion to the more potent androgen, DHT, can directly enhance sensitivity and sexual response.

A major pitfall with creams, particularly testosterone cream, is the potential for transference. The hormone can easily transfer to partners, children, or pets through skin-to-skin contact, potentially causing unintended and serious hormonal consequences for them. Furthermore, blood level monitoring with creams is notoriously unreliable. I have seen female patients using testosterone cream whose lab reports show serum levels over 2,000 ng/dL—a level typical for a healthy young man! Yet, they often don’t present with the severe masculinizing side effects one might expect, though they may sound a bit hoarse or have an “edge” to their voice. This discrepancy highlights that the hormone spike in the blood after application is often transient and doesn’t reflect a steady, usable level in the tissues. In essence, with creams, you are often left monitoring symptom relief rather than reliable lab values. For systemic, whole-body benefits, creams and standard transdermal patches fall short.

Oral Hormones: The Problem of First-Pass Metabolism

Oral options for hormone replacement exist, but they come with significant drawbacks, primarily due to the first-pass effect of liver metabolism. When you swallow a hormone like estradiol, it is absorbed through the gut and travels directly to the liver before it enters systemic circulation. The liver metabolizes a large portion of it, which not only reduces the amount of active hormone available to the body but also increases production of clotting factors and inflammatory proteins, raising the risk of thromboembolic events such as blood clots and stroke. For this reason, oral estradiol is not the preferred method for long-term hormone replacement.

I do have a handful of patients, my “sweet ladies” as I affectionately call them, for whom a low dose of oral 17-beta estradiol is the only affordable option. While not ideal, it can provide some relief. However, we must be vigilant in monitoring them.

A notable exception in the oral category is Clomiphene Citrate (Clomid). It’s an interesting and useful tool, particularly for younger men with low testosterone who wish to preserve fertility. Clomiphene is technically a SERM (Selective Estrogen Receptor Modulator). It works by blocking estrogen receptors in the hypothalamus and pituitary gland. This “tricks” the brain into thinking estrogen levels are low, causing it to increase the production of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). LH then signals the testes to produce more of their own natural testosterone.

I typically start men on a dose of 25 milligrams daily or every other day, as some find the 50mg dose to be almost “too effective,” leading to a hyper-sexual state. You must start low and titrate up based on their response. However, Clomiphene has its limitations. The LH signaling pathway can become less effective as men age. The testes may no longer respond as robustly to the LH signal. Therefore, it’s generally considered a good short-term option for a specific population, but not a long-term solution for most men, especially those over 40.

Injections: The Spike and Trough Rollercoaster

Testosterone injections are a very common and effective way to raise testosterone levels. They are popular in men’s health clinics and the bodybuilding world. However, they create a physiological pattern that is anything but natural: the “spike and trough” or “peak and valley” effect.

Immediately after an injection, testosterone levels skyrocket to supraphysiological (abnormally high) levels. The patient may feel great during this peak—energetic, confident, and with a high libido. However, as the week progresses, the hormone level begins to plummet, crashing down into a trough of low testosterone before the next scheduled shot. In this trough, all the symptoms of deficiency return: fatigue, irritability, and brain fog. This rollercoaster of hormone levels can be emotionally and physically taxing.

This large, unnatural bolus of testosterone also has metabolic consequences. A sudden spike in testosterone provides a massive amount of substrate for the aromatase enzyme, which converts testosterone into estradiol. This can lead to abnormally high estrogen levels in men, resulting in side effects like water retention, moodiness, and gynecomastia (breast tissue development). It also provides a surge of substrate for the 5-alpha reductase enzyme, leading to elevated DHT levels, which can exacerbate acne and hair loss in susceptible individuals. While injections are more effective than creams for systemic relief, managing these peaks, troughs, and side effects makes them a less-than-ideal modality for achieving stable, long-term well-being. This method is also less researched and not widely used for women due to the difficulty in administering the tiny doses required and the high risk of masculinizing side effects from the hormonal spikes.

The Superiority of Subcutaneous Pellets: A Deep Dive into the Gold Standard

After critically evaluating the various hormone delivery systems, my 16 years of clinical experience, combined with a wealth of scientific data, have led me to a clear conclusion: to achieve stable, systemic, and long-lasting hormone levels, subcutaneous bioidentical hormone pellets represent the gold standard. This is the modality we specialize in, and it’s what you’re here to learn about. The benefits are so significant that they have fundamentally changed how we approach hormone optimization.

Pellets are tiny, crystalline cylinders, about the size of a grain of rice, which are composed of bioidentical testosterone or estradiol. They are inserted into the subcutaneous fatty tissue, typically in the upper gluteal area, during a simple in-office procedure. Once in place, they are slowly metabolized by the body, releasing a small, consistent dose of hormone directly into the bloodstream 24 hours a day, 7 days a week.

The Unmatched Benefits of Pellet Therapy

The advantages of this delivery system are numerous and compelling, addressing the shortcomings of all other methods.

1. Continuous and Stable Hormone Delivery

This is the single most important benefit of pellet therapy. Unlike the daily fluctuations of creams or the weekly rollercoaster of injections, pellets provide a continuous, steady-state hormone level for several months. This physiological consistency mitigates the peaks and troughs that cause so many side effects and emotional volatility. Patients don’t experience the crash in mood and energy at the end of a cycle. They feel consistently well. This mimics the body’s natural hormone production far more closely than any other method, leading to superior symptom relief and a greater sense of overall well-being.

2. Enhanced Convenience and Compliance

The “set it and forget it” nature of pellets is a huge factor for patients. Instead of having to remember a daily cream or pill, or endure a weekly or bi-weekly injection, they undergo a simple procedure just a few times a year. Typically, females come in for pellet insertion about three to four times a year (every 3-4 months), and males about two to three times a year (every 4-6 months). This high level of convenience leads to near-perfect compliance, which is essential for achieving long-term therapeutic goals.

3. Individualized and Precise Dosing

Pellet dosing is not one-size-fits-all. It is highly individualized based on a patient’s symptoms, lab values, weight, and metabolic rate. We can precisely calculate the dose needed to bring a patient into their optimal range and keep them there. This precision is far more difficult to achieve with other modalities.

4. Reversible and Manageable Side Effects

All potential side effects associated with testosterone therapy—such as acne, oily skin, or hair growth—are dose-dependent and completely reversible. If a patient experiences a bothersome side effect, it can be easily managed by adjusting the dose at their next insertion. There are no permanent or deal-breaker side effects. In my extensive experience, I have never encountered a situation that required the surgical removal of pellets. I have heard stories of other clinicians resorting to this for a complication like cellulitis (a skin infection), which is profoundly misguided. A simple infection should be treated with antibiotics, not surgery. The notion that a patient must pay a surgeon to remove pellets, rather than have the provider treat the complication, is a failure of care. The only extremely rare instance I can conceive of for removal would be a sterile abscess that is not resolving, but in 16 years, this has not been necessary. The side effects are manageable, and for the vast majority of patients, the profound benefits far outweigh any minor inconveniences.

The Evolution of Pellet Formulation: The EvexiPEL Method

The reason this training is so robust is that we are constantly innovating. The question we always ask is, “How can we make this better?” This drive for excellence led to the development of the EvexiPEL method and its unique pellet formulation, which addresses some of the historical challenges of pellet therapy.

Around 2017, we began a collaboration with a pharmacist from Australia who had been pioneering the use of triamcinolone, a mild corticosteroid, in hormone pellets. The rationale was brilliant: the insertion of a foreign object (the pellet) into the body naturally elicits a localized inflammatory response. The body forms a fibrous capsule around the pellet, which can wall it off and impede its dissolution and absorption. By incorporating a minute amount of triamcinolone directly into the pellet, we could significantly reduce this local inflammation and scar tissue formation. The results were immediate and impressive, leading to more consistent absorption rates and better patient outcomes.

The second key innovation was the incorporation of ethylcellulose. In my career, I’ve worked with pellets from eight different compounding pharmacies, and I can state unequivocally that not all pellets are created equal. Some are pressed “softer,” causing them to dissolve too quickly. This can create a rapid spike in hormone levels shortly after insertion, which, while not as dramatic as an injection, can still increase the incidence of dose-dependent side effects like acne. I was constantly struggling to find the right balance—needing higher levels for symptom relief but trying to avoid the side effects from the initial spike.

The addition of ethylcellulose, a plant-derived polymer, solved this problem. It acts as a binding agent that slows down the dissolution of the pellet, creating a true sustained-release mechanism. It transforms the pellet into something akin to an “enteric-coated” tablet, ensuring a much smoother, more gradual release of the hormone. This has been a game-changer. It dramatically mitigates the side effects associated with hormone spikes. We see far less acne and, critically, much less aromatization. As I mentioned, a bolus of testosterone is a substrate for conversion to estradiol (via aromatase) and DHT (via 5-alpha reductase). By smoothing out the release, we don’t provide that massive initial substrate. Consequently, our male patients on these ethylcellulose-containing pellets do not experience the significant spikes in estradiol levels that are common with other pellets, especially with injections. This innovation alone has profoundly improved the safety and tolerability of pellet therapy.

The Science of the Press: Horizontal vs. Vertical

The level of detail we have explored extends even to the manufacturing process. Most compounding pharmacies press their pellets vertically. Imagine a cylinder filled with hormone powder being compressed from the top down. This process creates uneven pressure distribution, making the pellet densest at the top and bottom and softer in the middle. As the body dissolves this type of pellet, the dissolution rate is inconsistent. It starts slow, speeds up as it reaches the softer core, and then slows down again. This can cause a mid-cycle surge and then a drop-off, which patients experience as, “I felt great for a few weeks, and then suddenly, boom, my symptoms returned.”

The pharmacy we partner with is one of only two in the country that presses its pellets horizontally. The powder is compressed from both sides simultaneously. This creates a uniform density and pressure distribution throughout the entire pellet. The result is a truly linear and predictable dissolution rate from beginning to end. This meticulous attention to the physics of the manufacturing process ensures that the hormone delivery is as consistent and reliable as possible, eliminating the frustrating mid-cycle crashes. This is the kind of “crazy science” I get excited about, because it translates directly into better, more predictable results for our patients. It’s a clear demonstration that Pharmacy A down the street is not producing the same product as a highly specialized compounding pharmacy, and the patient’s response will reflect that difference.

The Testosterone Conundrum: Beyond the Numbers

When we shift our focus to testosterone, especially in women, we enter a realm of medicine that has been historically fraught with misunderstanding and controversy. The question of what constitutes a “normal” testosterone level for a woman is complex, and the conventional approach of strictly adhering to laboratory reference ranges has, in my opinion, done a great disservice to countless symptomatic patients. I am particularly passionate about this topic and have authored a white paper, available to our patients and colleagues, that delves into the evidence supporting a more nuanced, symptom-based approach. This is an area where states like Alabama and Louisiana have historically held very conservative views, often discouraging the use of testosterone in women. My work aims to provide the robust scientific justification needed to move past these outdated and restrictive perspectives. We must stop chasing arbitrary numbers and start focusing on patient outcomes.

Several key research papers have addressed this very issue, questioning the validity of established “normal” blood level ranges used to define androgen status. A pivotal study in the journal Menopause by Davis et al. makes a powerful statement. The authors note that while low testosterone is associated with a wide array of symptoms—including low libido, fatigue, cognitive fog, anxiety, and depression—the diagnosis of female androgen insufficiency syndrome should be based primarily on the presence of these clinical symptoms, in conjunction with a finding of a low testosterone level. Their conclusion is a direct challenge to the status quo: despite the complexities of defining this syndrome biochemically, symptoms have been consistently and effectively reversed with testosterone therapy.

Study after study echoes this sentiment. There is a notoriously poor correlation between a woman’s reported symptoms of androgen deficiency and her measured serum testosterone level, whether we look at total, free, or bioavailable testosterone. The Endocrine Society and other conventional bodies would have us believe that these lab values are the definitive measures of androgen status. Still, clinical reality and a growing body of research prove otherwise. The problem is that a blood test can only measure what is circulating in the serum. It cannot tell us what is happening at the cellular level. There can be insufficient production of testosterone from the ovaries and adrenal glands, and concurrently, there can be variable degrees of resistance at the androgen receptor sites. These are critical factors influencing hormone efficacy that we cannot measure with a standard blood test. The overarching point of all this research is that a patient’s symptoms are the most reliable indicator of androgen insufficiency.

A New Paradigm for Female Testosterone Therapy

No discussion on this topic is complete without mentioning the groundbreaking work of Dr. Rebecca Glaser. As a breast cancer surgeon who uses testosterone therapy extensively for her patients, including breast cancer survivors, she is one of the leading voices advocating for a paradigm shift. Her 2013 paper, “Testosterone therapy in women: myths and misconceptions,” is a must-read for any practitioner in this field. She meticulously reviewed the available literature and systematically dismantled the idea that we should be afraid of achieving what some might call “supraphysiologic” levels.

Dr. Glaser’s research and clinical practice show that, to achieve positive outcomes, particularly in post-menopausal women, we often need to reach serum levels higher than those achieved by endogenous production in a healthy young female. Her paper states unequivocally: “There is no clinical evidence supporting the recommendation that serum levels…should remain within the upper limits of endogenous production for a young, healthy female.” What she and many of us in the field have observed is that perimenopausal and post-menopausal women often require higher testosterone levels to feel well and to experience the protective benefits of the hormone. Even younger women, such as those in their 20s and 30s with symptoms of deficiency (often due to oral contraceptives), respond remarkably well to testosterone therapy. They tend to have higher levels of sex hormone-binding globulin (SHBG), which means they need a higher total testosterone to achieve an adequate free, usable testosterone level.

Another one of Dr. Glaser’s critical papers reinforces this, concluding that “pharmacological dosing of subcutaneous testosterone is needed to produce physiological effects in female patients.” This is a key concept. “Pharmacological dosing” means using a dose sufficient to elicit a therapeutic effect, which may result in a serum level above the conventional reference range.

Dr. Glaser provided me with a brilliant visual analogy to explain this concept. Imagine the hormone’s journey:

1. Production: The ovaries, testicles, and adrenal glands produce hormones like testosterone and DHEA.
2. Circulation: This creates a measurable serum level in the blood. This is what we test with a lab draw.
3. Action: The hormone is then metabolized and must travel to the target cell, bind to a receptor, and exert its biological effect. This final, most crucial step is beyond the reach of our current tools.

Her point is profound: we must pay attention to the outcomes—the resolution of symptoms, the improvement in well-being, the positive changes in body composition and energy. While we don’t ignore the labs, we cannot rely solely on them. The labs are a starting point, a guide, and a tool for monitoring safety, but they are not the ultimate arbiter of a patient’s hormonal needs.

Optimizing Testosterone in Men: The Importance of Estradiol

The principle of optimizing hormones to the upper end of the normal range is just as critical for men, if not more so. Decades of clinical studies and my own extensive practice experience have shown that optimal health outcomes—not just symptom relief, but also long-term disease prevention—are most consistently seen when a man’s testosterone levels are in the upper tertile (the top third) of the laboratory reference range.

But the story doesn’t end with testosterone. One of the most significant and often overlooked aspects of male hormone optimization is the role of estradiol. Testosterone converts to estradiol via the enzyme aromatase. As we’ve seen more and more research emerge, it’s becoming increasingly clear that it is actually the estradiol that is responsible for many of testosterone’s most important protective benefits in men. This includes benefits for cardiovascular health (protecting the endothelium of blood vessels), bone density, and even prostate health.

Men need a total testosterone level in that upper tertile specifically to generate enough estradiol to be therapeutic. As men age, their testosterone levels naturally decline, leading to a concurrent decline in estradiol. This is a contributing factor to the increased risk of heart disease and benign prostatic hyperplasia (BPH) that we see in aging men. By restoring testosterone to an optimal level, we are also restoring this crucial, protective estradiol. Direct free testosterone levels also closely correlate with symptom improvement, and targeting the upper tertile of this marker is a primary goal.

Enhancing Free Testosterone with Nutraceuticals

Even when we optimize total testosterone, some patients, both male and female, may still experience persistent symptoms. This is often because their free testosterone—the unbound, biologically active portion—remains suboptimal. We see this in lab work all the time: a patient has a good total testosterone level, but their free testosterone is languishing in the lower part of the range, and they still feel fatigued and have low libido.

This is where targeted nutraceutical intervention can be a true game-changer. For years, the only solution was to keep increasing the total testosterone dose, sometimes to very high levels, to push that free T up. However, I have found an incredibly effective alternative. A supplement that combines Trigonella foenum-graecum (Fenugreek) extract with Shilajit has revolutionized my ability to manage these patients. Shilajit, in particular, has been shown in clinical studies to boost free testosterone levels naturally. By adding this supplement to a patient’s regimen, we can significantly increase their free testosterone without further increasing their total testosterone dose.

In my clinic, I’ve seen it work time and again. A patient’s symptoms resolve, their energy returns, and their libido improves, all while maintaining their total testosterone at a safe, stable level. Utilizing this specific supplement has allowed us to avoid running unnecessarily high testosterone levels, providing a safer and more elegant solution for achieving optimal androgenic effects. It’s a powerful tool to have in our clinical toolbox.

The Optimization Pyramid: A Smart, Layered Approach to Treatment

To achieve consistent and sustainable results in hormone optimization, we must work smarter, not harder. This means adopting a structured, systematic, and layered approach to patient care. I call this the “Optimization Pyramid,” a method that ensures we address foundational issues first before moving on to more specific interventions. This prevents us from overwhelming the patient’s system and allows us to identify the cause-and-effect of each treatment clearly.

The Foundational Steps of Our Method:

1. Screening and Documentation: It all begins with a thorough baseline screening, including the comprehensive lab panels we’ve discussed and detailed symptom questionnaires. We use tools such as the Menopause Rating Scale (MRS) and other validated instruments to obtain a quantifiable measure of a patient’s symptoms at the outset. This documentation is crucial for tracking progress.
2. Hormone Optimization with BHRT: The primary intervention is to balance and optimize the sex hormones—estrogen, progesterone, and testosterone—using bioidentical hormone replacement therapy (BHRT). In our practice, we find that subcutaneous pellets offer the most consistent, steady-state hormone delivery, avoiding the daily peaks and troughs seen with other methods.
3. Thyroid Evaluation and Optimization: The thyroid is the master gland of metabolism. Its function is inextricably linked to sex hormone balance and overall energy. We evaluate thyroid function comprehensively and optimize it as needed.
4. Gut Health Assessment: The gut is a central processing hub for the entire body, influencing inflammation, nutrient absorption, and even hormone metabolism through the estrobolome. We assess gut health through simple but effective questions on our intake forms, such as asking about daily bowel movements, bloating, and gas.
5. Targeted Nutraceuticals: We use key proprietary nutraceutical supplements, such as a Shilajit-containing formula to boost free testosterone, to address specific biochemical needs and enhance the effects of our hormone therapy.
6. Structured Follow-Up: We maintain a consistent cadence of follow-up appointments, typically every 3 to 5 months. This allows us to monitor progress, review follow-up labs, and make precise adjustments to the treatment plan.

The Art of Layering: When to Introduce New Therapies

The “art” of this medical practice lies in the strategic layering of treatments. It’s easy for an enthusiastic practitioner, armed with a wealth of new knowledge, to want to fix everything at once. You identify low testosterone, low estrogen, suboptimal thyroid, low DHEA, and inflammation, and the temptation is to throw a handful of prescriptions and supplements at the patient on day one. This is a mistake. If the patient has an adverse reaction or doesn’t feel well, it becomes impossible to determine which intervention caused it.

My protocol is to layer therapies logically. At the initial visit, I address the most glaring and impactful issues, which are almost always the sex hormones. We will start the patient on testosterone and, if post-menopausal, estrogen and progesterone. We let that foundation settle in. The follow-up visit, which occurs approximately 4-6 weeks after their first pellet insertion, is the ideal time to introduce the next layer. At this post-pellet visit, I will review their progress and their new labs. If their DHEA-S remains low, I will add DHEA supplementation. If their thyroid still needs fine-tuning, we will address that then. If weight loss is a goal and their metabolic hormones are now balanced, this is the perfect time to consider adding a GLP-1 receptor agonist.

I was recently asked if I would start a GLP-1 agonist at the same time as the initial hormone pellets. My answer is unequivocally no. I always optimize the foundational metabolic hormones first. When a patient’s testosterone and estrogen are optimized, their energy improves, their insulin sensitivity increases, and their body composition begins to shift. They already feel better. Then, if we add a GLP-1, we can achieve much better results with fewer side effects. If you start everything simultaneously and the patient experiences nausea or fatigue from the GLP-1, they will invariably and incorrectly blame the hormone pellets. Layering therapies allows for precision, safety, and patient compliance.

Clinical Pearls: Navigating Common Patient Scenarios

Over years of practice, you accumulate a wealth of clinical “pearls”—nuggets of wisdom that help you navigate common and sometimes complex patient situations with confidence and efficacy. Here are some of the most important ones that we apply in our clinic every day.

Transitioning Patients to Pellets

A frequent scenario is a new patient who is already on another form of HRT and wants to switch to pellets. It is critical to manage this transition smoothly to avoid a “gap” in their hormone levels, which can cause a disruptive return of symptoms.

• Patients on Estrogen (Patches, Gels, Pills): Estrogen from pellets reaches therapeutic levels very quickly, typically within 3 to 5 days. Therefore, if a woman comes to us on an estrogen patch, we perform the pellet insertion and instruct her that she can stop using her patch immediately. There is no need for an extended overlap.
• Patients on Testosterone (Shots, Gels, Creams): Testosterone from pellets has a slower onset of action. It takes longer for the pellets to reach a steady therapeutic level. To bridge this gap, men or women currently on any other form of testosterone need to continue their existing modality for two weeks after the pellet insertion. For example, a man on weekly testosterone injections should continue his shots for two more weeks. It actually takes about two months for the pellet to mature and deliver its full peak dose. Still, this two-week overlap is sufficient to ensure a seamless transition and prevent the patient from experiencing a dip in their levels and a return of symptoms like fatigue and brain fog.

The Perimenopause Solution: The 6mg Estrogen Game-Changer

Perimenopause is arguably the most challenging time for women and, by extension, their partners and families. I often say that this is the worst time for marriages, and it’s only partly a joke. More divorces happen during this life stage than any other. Women feel like they are going crazy. They are moody, anxious, not sleeping, and experiencing hot flashes, all while their cycles become erratic. As I often explain to couples, a man can handle a partner’s moodiness, but he can’t handle perpetual bad moods combined with a complete loss of libido. This is the reality of perimenopause: women are moody and have no desire for intimacy. It’s a recipe for relationship disaster.

The physiological reason for this turmoil is the wild fluctuation in estrogen levels. The ovaries are sputtering, leading to precipitous drops in estrogen that trigger symptoms. You can save marriages and restore sanity with a simple, elegant solution: a 6 mg estradiol pellet.

So, when do we use this?

• A patient does not have a uterus (due to hysterectomy) or has had a uterine ablation, so we cannot use menstrual cycles as a guide. Her FSH may be only mildly elevated (e.g., 25-35), so we’re not sure if she’s fully menopausal.
• A patient is clearly in perimenopause, with fluctuating cycles and a volatile symptom profile.

In these cases, a standard post-menopausal dose of estrogen (e.g., 12 or 15 mg) would be far too much. Her ovaries are still producing some estrogen, and adding a large dose on top of that would lead to side effects like severe breast tenderness, fluid retention, and heavy, erratic bleeding. She would be miserable.

The 6 mg estradiol pellet, however, is a game-changer. It acts as a basal level of estrogen, creating a hormonal floor. It smooths out the peaks and, more importantly, fills in the troughs. By preventing her estrogen from ever dropping to zero, it stops the hot flashes, stabilizes her mood, and restores her sense of well-being. I have seen this small dose transform patients’ lives. If you are ever unsure of a woman’s menopausal status or if she is definitively perimenopausal, starting with a conservative 6 mg estradiol pellet is a safe, effective, and life-altering strategy.

Dosing Considerations for Specific Patient Populations

The dosing calculator we use is designed with built-in logic to account for many variables, taking much of the guesswork out of the initial dosing. However, some clinical judgment is always required.

• Patients on Pain or Psychiatric Medications: Patients on chronic opioid therapy for pain or on certain medications for ADD/ADHD often require a higher starting dose of testosterone. These medications can impact hormone metabolism and receptor sensitivity. Similarly, patients on multiple psychotropic medications, like antidepressants or antipsychotics, may have a blunted response.
• “Sensitive” Patients: Conversely, we must be cautious with patients who report being “sensitive to everything.” If a patient tells you that half a Tylenol makes them drowsy or 25 mg of Benadryl knocks them out for a day, listen to them. These individuals often have unique metabolic pathways (e.g., slow COMT or MTHFR genetics) and require a lower initial dose. Starting low and titrating up is the prudent approach.
• High BMI: In patients with a high Body Mass Index (BMI), the testosterone dose will generally need to be higher to account for the larger volume of distribution and increased aromatization to estrogen that occurs in adipose tissue.

Special Considerations: Breastfeeding, Pregnancy, and Migraines

• Breastfeeding: I am often asked if it is safe to provide testosterone therapy to breastfeeding mothers. This is a delicate subject. There is one small but significant study (n=1) conducted by Dr. Glaser. She took a breastfeeding mother who was on testosterone pellets and performed serial measurements of the testosterone levels in her breast milk at various times over a week. The result was zero detectable testosterone in the breast milk. I explain this study to my patients. I tell them it’s a very small study, but it’s the best data we have, and it suggests there is no crossover. The decision is ultimately theirs. In my experience, first-time moms are often more hesitant, while second or third-time moms, who are exhausted and depleted, are usually eager to proceed. We have the conversation, provide the data, and respect their choice.
• Pregnancy on Pellets: Obviously, we do not pellet a woman whom we know is pregnant. Testosterone is classified as a teratogen. However, it is crucial not to extrapolate the severe teratogenic effects of high-dose anabolic steroids to the physiological or pharmacological doses of bioidentical testosterone we use. They are not the same. We have had many women accidentally become pregnant while on pellets. In these cases, the outcome is fine. We do not insert any more pellets once the pregnancy is confirmed. The baby will be healthy. The key is to stop treatment during the pregnancy and resume postpartum if desired.
• Menstrual Migraines: For women who suffer from debilitating migraines that are clearly linked to their menstrual cycle, a 6 mg estradiol pellet can be miraculous. These cyclical migraines are often triggered by the sharp drop in estrogen that occurs just before menstruation. By providing that same basal level of estrogen we use for perimenopause, we can abort these migraines in over 90% of cases. I have had patients who have seen multiple neurologists and tried every medication on the market with no relief, only to find a complete resolution with this simple hormonal intervention. It can be truly life-changing. While trying testosterone first can sometimes help, the most definitive solution for cyclical migraines is almost always low-dose estradiol.

The Problem with Shots in Women

While testosterone injections are common for men, they are a problematic and generally ill-advised option for women. More and more, I am seeing female patients who have been put on testosterone shots by other clinics. This is often driven by the bodybuilding world, where high doses are used for their anabolic effects.

The primary issue is the inability to achieve appropriate dosing. Women require a tiny fraction of the testosterone dose that men do. Trying to draw up and administer such a minuscule amount from a vial designed for male dosing is fraught with inaccuracy. More importantly, even a “small” injection creates a massive, supraphysiological spike in a woman’s body. This inevitably leads to a high incidence of virilizing (masculinizing) side effects: a deepened voice, clitoral enlargement (clitoromegaly), facial hair growth, and severe acne. I have seen it time and again in my practice. Women come in seeking help to reverse these side effects, which are often slow to resolve, if at all. For these reasons, testosterone injections are not a safe or recommended modality for women in a therapeutic context. Pellets and, to a lesser extent, properly compounded creams for local use are far superior and safer options.

Weaning Patients from SSRIs

One of the most rewarding parts of my practice is helping patients get off unnecessary medications. A classic scenario is the woman in her late 30s or early 40s who, after her second or third child, feels exhausted, foggy, and “depressed.” She went to her primary care provider or OB/GYN and was promptly placed on an SSRI (Selective Serotonin Reuptake Inhibitor) like Prozac or Zoloft. The problem is that a serotonin deficiency did not cause her symptoms; a progesterone and testosterone deficiency caused them.

The two most common side effects of SSRIs are weight gain and low libido—the very things we are trying to fix with hormone therapy! When it is clinically obvious that a patient’s depressive symptoms were the result of a hormonal decline, I will initiate a plan to wean them off the SSRI at their very first visit. We have a specific SSRI Weaning Protocol available to our patients.

There are two primary methods, and the patient can choose which they prefer:

1. Option 1 (My Preferred Method): I have them do it on an interval schedule. For two weeks, they take their current dose every other day. For the following two weeks, they take it every third day, and so on, until they are off completely.
2. Option 2 (Dr. Tutera’s Method): This involves cutting the dose in half and taking that reduced dose daily for a period, then halving it again.

The most important caveat I give every patient is this: “If at any point in this process you start to feel ‘off’ or unwell, go back to the last lowest dose where you felt good. Stay there for a week or two to stabilize, and then you can resume the downward titration.” This process requires patience. I had one patient who had been on Prozac for over 20 years. It took us nearly a full year to wean her off completely, but we did it, and she is now thriving on hormones alone. The key is to be patient and listen to your body.

The Follow-Up Process: Monitoring, Boosting, and Refining

The journey of hormone optimization does not end with the first pellet insertion. The follow-up process is where we refine our approach to ensure the patient achieves and maintains optimal results. Our standard protocol involves follow-up labs drawn approximately four to five weeks after the initial pelleting.

At this follow-up visit, we gather several key pieces of data:

1. Follow-up Labs: We recheck hormone levels (FSH, estradiol, total and free testosterone) to assess the biochemical response to therapy.
2. Symptom Score: The patient completes the same symptom questionnaire (e.g., Menopause Rating Scale) they did at baseline. This allows us to measure the improvement in their symptoms objectively.
3. Subjective Feedback: We have a detailed conversation about how they are feeling.

The Concept of a “Boost”

Sometimes, despite a good initial dose, a patient may still have some lingering symptoms at their 4-week follow-up. Their labs might look good, but not perfect, and their symptom score shows improvement, but not complete resolution. In these cases, they may benefit from a “boost.”

A boost is a small, additional dose of testosterone or estrogen administered at this 4-week post-pellet visit. It’s designed to “top off” their levels and address any remaining symptoms without waiting for their next full pelleting cycle. The decision to boost is based on the combination of their lab results, symptom score, and subjective report. I will show you exactly what this looks like and how to decide on a boost dose when we review case studies.

Dosing for the Next Round

When the patient returns for their second, third, and subsequent pellet insertions (typically every 3-5 months), we must decide on the new dose. Our advanced dosing calculator is an invaluable tool here. It takes the data from their previous cycles—the dose they received, their follow-up lab values, and their symptom improvement—and uses an algorithm to recommend a new, more precise dose.

By the time we get to the third or fourth pellet insertion, we have typically figured out the patient’s ideal dose and cadence (how many months they can go between insertions). However, the decision-making process always involves asking some key questions:

• How long did the last round of pellets last before symptoms started to return?
• What specific symptoms were the first to return? (e.g., “My hot flashes came back at month 4,” or “My energy and focus started to dip around 12 weeks.”)
• Did they experience complete symptom relief at the peak of the cycle?

This combination of objective data from the calculator and subjective feedback from the patient allows us to continually refine their therapy, ensuring they feel their best for as long as possible. This iterative process of consultation, lab review, pelleting, and follow-up is the cornerstone of successful long-term hormone management.

We have invested heavily in creating a seamless and educational experience for our associated practitioners. For many years, we’ve been asked if our educational seminars offer Continuing Medical Education (CME) credits. I am pleased to say that we now have an online platform that provides CME credits, allowing us to share this vital information with a broader audience of medical professionals dedicated to improving patient lives through evidence-based hormone optimization.

Summary

This comprehensive post has navigated the intricate landscape of hormone insufficiency and its treatment from my perspective as Dr. Alexander Jimenez, DC, APRN, FNP-BC. We began by establishing the necessity of comprehensive baseline lab work for both male and female patients, moving beyond minimal panels to include markers of inflammation, vitamin status, and metabolic health, such as CRP, Vitamin D, and HbA1c. We then explored the critical role of FSH as the most accurate indicator of menopausal status and a tool for guiding estrogen therapy, intending to suppress elevated FSH levels to below 25 for optimal outcomes. A significant focus was placed on re-evaluating the approach to testosterone therapy, particularly in women. Citing leading researchers such as Dr. Rebecca Glaser, we argued for prioritizing symptom resolution over strict adherence to outdated lab reference ranges, recognizing that pharmacological dosing is often required to achieve physiological effects at the cellular level. The core of our discussion was a critical, evidence-based evaluation of various hormone-replacement modalities. We detailed the limitations of creams for systemic use, the metabolic risks of oral estrogens, and the physiological rollercoaster of hormone injections.

In contrast, we presented subcutaneous bioidentical hormone pellets as the gold standard, prized for their ability to provide stable, continuous hormone delivery. We delved into the advanced science behind the EvexiPEL method, explaining how the inclusion of triamcinolone reduces inflammation and how ethylcellulose creates a sustained-release effect. The “Optimization Pyramid” was presented as a structured, layered treatment methodology, emphasizing the optimization of sex hormones first, followed by the strategic layering of therapies for the thyroid, gut, and adrenals (including DHEA). Clinical pearls were shared for managing common scenarios, including the use of 6 mg estradiol pellets as a game-changing intervention for perimenopause and menstrual migraines, and safe protocols for weaning patients from SSRIs.

Conclusion

The practice of hormone optimization is both a science and an art. The science lies in understanding the complex physiology of the endocrine system, correctly interpreting laboratory data, and staying abreast of the latest evidence-based research. The art lies in listening to the patient, understanding their unique clinical presentation, and strategically layering therapies safely and effectively, tailored to the individual. Modern, evidence-based research, coupled with extensive clinical experience, demonstrates that restoring hormonal equilibrium is key to alleviating a wide spectrum of physical and psychological ailments. While various delivery methods exist, subcutaneous bioidentical hormone pellets, particularly those engineered with advanced formulations, offer an unparalleled solution. They provide the stable, physiological hormone levels necessary to truly resolve symptoms and restore vitality without the volatility associated with other methods. By embracing these principles, we can empower our patients to move beyond hormonal imbalance and reclaim their vitality, mental clarity, and overall well-being. This approach does not just treat symptoms; it transforms lives by addressing the root cause of dysfunction and optimizing the very foundation of metabolic health.

Key Insights

• FSH is the Gold Standard: For diagnosing menopause and guiding estrogen therapy, FSH is the most reliable marker. The therapeutic goal is to suppress elevated FSH by at least 50% initially, with a long-term target of below 25 mIU/mL for optimal health benefits.
• Symptoms Trump Labs for Testosterone: For both men and women, but especially women, clinical symptoms of androgen deficiency (fatigue, low libido, brain fog) are more important than a specific serum testosterone number. Achieving symptom resolution often requires pharmacological doses that may place levels in the upper quartile of or slightly above standard reference ranges.
• Layer Therapies Strategically: Do not introduce all interventions at once. Begin by optimizing foundational sex hormones (estrogen, progesterone, testosterone). At the first follow-up (4-6 weeks), layer in secondary treatments like DHEA, thyroid support, or GLP-1 agonists. This isolates variables and improves safety.
• The 6 mg Estradiol Pellet is a Powerful Tool: For perimenopausal women with fluctuating hormones or women with cyclical migraines, a low-dose 6 mg estradiol pellet provides a stable hormonal “floor,” preventing symptomatic troughs and dramatically improving quality of life.
• Pellets Offer Physiological Stability: Subcutaneous pellets are the superior modality for systemic hormone replacement because they deliver a continuous, stable dose of hormone, mimicking the body’s natural function and avoiding the rollercoaster effects of other methods.
• Hormones Over Antidepressants: Many symptoms of depression and anxiety in midlife are due to hormonal decline, not a primary serotonin deficiency. When clinically appropriate, weaning patients from SSRIs while optimizing their hormones can resolve symptoms and eliminate medication side effects like weight gain and low libido.

Keywords: Hormone Insufficiency, Hormone Replacement Therapy, Low Testosterone, Bioidentical Hormones, Testosterone Pellets, Estrogen Deficiency, Dr. Alexander Jimenez, EvexiPEL, Subcutaneous Pellets, Hormone Optimization, Chronic Pain, Fibromyalgia, Menopause, Perimenopause, Andropause, Libido, Hormone Imbalance, Functional Medicine, FSH, Clomiphene, Estradiol Patch, Progesterone, DHEA, SSRI Weaning, Shilajit, Clinical Pearls, Evidence-Based Medicine.

References:

1. Glaser, R., & Dimitrakakis, C. (2013). Testosterone therapy in women: myths and misconceptions. Maturitas, 74(3), 230-234.
2. Davis, S. R., & Wahlin-Jacobsen, S. (2015). Testosterone in women: the clinical significance. The Lancet Diabetes & Endocrinology, 3(12), 980-992.
3. Traish, A. M. (2014). The health benefits of testosterone. Journal of Education, Health and Sport, 4(8), 223-241.
4. Glaser, R. L., & York, A. E. (2019). Subcutaneous testosterone-letrozole therapy in a premenopausal woman with recurrent invasive breast cancer. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819851992.
5. Pandit, S., Biswas, S., Jana, U., De, R. K., Mukhopadhyay, S. C., & Biswas, T. K. (2016). Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia, 48(5), 570-575.
6. Donovitz, G. S. (2013). A new and improved method of calculating doses for testosterone pellets. International Journal of Pharmaceutical Compounding, 17(3), 244-248.
7. Taylor, F., & Al-Azzawi, F. (2020). The effect of testosterone on women’s health. Climacteric, 23(sup1), S8-S14.

Disclaimer: The information contained in this educational post is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. It is based on the clinical experience and research interpretation of Dr. Alexander Jimenez, DC, APRN, FNP-BC. The field of medicine is constantly evolving, and the information presented here may not be the most current.

Medical Advice Disclaimer: Do not use the information in this post for diagnosing or treating a health problem or disease. It is not a recommendation for any specific treatment plan, product, or course of action. All individuals are unique and require a personalized assessment. You must consult with your own medical provider or other qualified health care professional regarding any medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read in this post.

Personalized Medical Advice Disclaimer: Every individual’s health situation is unique. The treatment strategies, dosing information, and clinical scenarios discussed in this post are examples and may not be appropriate for your specific circumstances. All individuals must obtain recommendations for their personal health directly from their licensed medical providers, who can assess their specific needs and medical history. Never disregard professional medical advice or delay in seeking it because of something you have read here.